Zealand Pharma A/S
ZLDPF
$66.12
$3.625.79%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.59M | -39.26M | -42.24M | -33.29M | -38.22M |
| Total Depreciation and Amortization | 506.80K | 912.30K | 975.80K | 963.60K | 511.30K |
| Total Amortization of Deferred Charges | 2.36M | -- | -- | -- | 172.70K |
| Total Other Non-Cash Items | -6.23M | -2.79M | 6.58M | 1.81M | 8.09M |
| Change in Net Operating Assets | 19.17M | -2.39M | 1.30M | -664.30K | 38.04M |
| Cash from Operations | -25.79M | -43.52M | -33.38M | -32.57M | 8.59M |
| Capital Expenditure | -168.10K | -37.10K | -735.00K | -514.10K | -970.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.71M | -895.13M | -3.66M | -200.20M | 1.94M |
| Cash from Investing | 21.54M | -895.16M | -4.39M | -200.71M | 966.90K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 369.87M | -- |
| Total Debt Repaid | -4.59M | -4.18M | -3.82M | -3.86M | -8.63M |
| Issuance of Common Stock | 81.00K | 5.11M | 7.04B | 1.48B | 14.81M |
| Repurchase of Common Stock | 0.00 | -270.80M | -81.03M | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00K | -2.36M | -211.17M | -22.95M | -585.00K |
| Cash from Financing | -658.10K | -40.12M | 973.05M | 265.24M | 808.10K |
| Foreign Exchange rate Adjustments | 517.50K | -288.20K | 136.40K | 527.40K | -1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -100.00 | 100.00 | -- | -- |
| Net Change in Cash | -4.39M | -979.09M | 935.42M | 32.48M | 9.36M |